-
Hymon® Urine Bladder Cancer Screening
HymonBio Bladder Cancer Gene Methylation Detection Kit is used to detect specific gene methylation of exfoliated cells in urine. This kit uses innovative multi-gene detection technology, combined with original NPC Nucleic Acid Extraction technology to better protect the integrity of cellular DNA and greatly improve sensitivity and specificity. The sensitivity was 92%, and the specificity was 94%. The kit uses non-invasive urine samples, making testing convenient and improves compliance, and providing a non-invasive technical means for monitoring recurrence after clinical treatment.
-
Hymon® Blood Gastric Cancer Screening
HymonBio Gastric Cancer Gene Methylation Detection Kit uses 2 specific gene methylation of circulating tumor DNA (cfDNA) in blood samples. This kit uses innovative multi-gene detection technology, combined with original Magnetic Bead Extraction technology improving efficiency of low-concentration small fragment cell-free nucleic acid, and hence has higher sensitivity and specificity; clinical studies have shown a sensitivity of 89% and specificity of 91%. The kit uses non-invasive blood samples, making testing convenient and improves compliance, and providing a non-invasive technical means for monitoring recurrence after clinical treatment.
-
HAEMOCERT™ Colorectal Cancer Screening Test
HAEMOCERT™ Colorectal Cancer Screening Test has passed CE certification and is used for early colorectal cancer screening. Tests for 3 gene methylation and 1 gene mutation. -
Hymon® BCR-ABL Tyrosine Kinase Gene Detection Kit
Targeted medication for chronic myeloid leukemia. Confirmed mutation: recommended therapies include imatinib, treatment options and drug efficacy evaluation
-
Hymon® IDH1, IDH2 and FLT3 Gene Mutation Detection Kit
Targeted medication for acute myeloid leukemia. Confirmed mutation: recommended medications include ivosidenib, enasidenib, gilteritinib, midostaurin
-
Hymon® BRAF Gene Mutation Detection Kit
Targeted medication for non-small cell lung cancer and melanoma. Confirmed mutation: recommended medications include dabrafenib, vemurafenib, trametinib, etc.
-
Hymon® RET Gene Mutation Detection Kit
Targeted medication for non-small cell lung cancer. Confirmed mutation: recommended medications include pratinib, selpercatinib,
etc. -
Hymon® Met Gene Mutation Detection Kit
Targeted medication for non-small cell lung cancer. Confirmed mutation: recommended medications include savolitinib, gumetinib, etc.
-
Hymon® ROS1 Fusions Gene Detection Kit
Targeted medication for non-small cell lung cancer. Confirmed mutation: recommended medications include emtricinib, crizotinib, ceritinib, etc.
-
Hymon® EML4-ALK Fusion Gene Detection Kit
Targeted medication for non-small cell lung cancer. Confirmed mutation: recommended medications include crizotinib, ceritinib, alectinib, etc.
-
Hymon® EGFR Gene Mutation Detection Kit
Targeted medication for non-small cell lung cancer. Confirmed mutation: recommended medications include gefitinib, afatinib, dacomitinib, erlotinib, osimertinib, etc.
-
Hymon® KRAS Gene Mutation Detection Kit
Targeted medication for colorectal cancer. Confirmed mutation: the patient is not suitable to use cetuximab or panitumumab.
